Vault-13

AKARI THERAPEUTICS PLC

SPONSORED ADR · CUSIP 00972G207

11 institutional holders +2 vs Q1 2024
180,188180.2k shares reported held*
$488.1kreported value*
4 new 1 added 1 reduced 2 sold out net bought ≈ $14.7k (+5.4k shares)

* Summed across managers. Shares that two managers' reports both contain – a subsidiary's holdings that its parent's report includes too, or a sub-adviser's in its client's – are counted once. Holder counts are more reliable. Implied quarter-end price ≈ $2.71.

Trends to Q2 2024

Institutional holders

Managers reporting a position, each quarter

051015Q3 23: 8Q4 23: 8Q1 24: 9Q2 24: 1111Q3 23Q4 23Q1 24Q2 24
Numbers
QuarterHolders
Q3 20238
Q4 20238
Q1 20249
Q2 202411

Buyers vs sellers

Managers adding to or starting a position, vs cutting or selling out

Bought or addedCut or sold out
505Q4 23: 3 bought or addedQ4 23: 3 cut or sold outQ4 23Q1 24: 4 bought or addedQ1 24: 1 cut or sold outQ1 24Q2 24: 5 bought or addedQ2 24: 3 cut or sold outQ2 24
Numbers
QuarterBought or addedCut or sold out
Q4 202333
Q1 202441
Q2 202453

Biggest buyers

Cresset Asset Management, LLC New +18,408+18.4k
SUSQUEHANNA INTERNATIONAL GROUP, LLP New +17,226+17.2k
UBS Group AG New +15,953+16.0k
RENAISSANCE TECHNOLOGIES LLC Added +2,300+2.3k
OSAIC HOLDINGS, INC. New +100+100

Biggest sellers

SABBY MANAGEMENT, LLC Sold out -48,491-48.5k
Truvestments Capital LLC Sold out -50-50
MORGAN STANLEY Reduced -12-12

Major shareholders (over 5%)

Anyone who owns more than 5% of a class of the company's shares has to say so: on Schedule 13D if they may try to influence or control the company, on 13G if they're a passive investor, and update it as the stake changes. Each holder's latest filing, from 19 Dec 2024 on; percentages are of the share class, as the holder worked them out.

HolderStakeChangeShares Last filed
Huh Hoyoung 13G · exempt (held before listing) +2.9 pts · filed 2026-03-04 18.4% +2.9 pts 18.2bn 2026-03-04
Patel Samir Rashmikant 13D · may seek influence filed 2026-03-04
Stated purposeOn December 17, 2025, Dr. Patel purchased the securities described in the transactions as described in Item 3 above. Full filing
10.4% 9.7bn 2026-03-04
Prudo-Chlebosz Raymond 13D · may seek influence -0.4 pts · filed 2026-03-04
Stated purposeOn December 17, 2025, Dr. Prudo purchased the securities described in the transactions as described in Item 3 above. Full filing
8.9% -0.4 pts 8.4bn 2026-03-04

Holders, Q2 2024

#ManagerLocationShares Value% of their portfolioChangeShares change
1 Omnia Family Wealth, LLC 0.10% of their portfolio AVENTURA, FL 87,62887.6k $236.6k $236.6k 0.10% Unchanged
2 Cerity Partners LLC 0.00% of their portfolio NEW YORK, NY 23,64323.6k $63.8k $63.8k 0.00% Unchanged
3 Cresset Asset Management, LLC 0.00% of their portfolio Chicago, IL 18,40818.4k $49.7k $49.7k 0.00% New
4 SUSQUEHANNA INTERNATIONAL GROUP, LLP 0.00% of their portfolio BALA CYNWYD, PA 17,22617.2k $48.1k $48.1k 0.00% New
5 RENAISSANCE TECHNOLOGIES LLC 0.00% of their portfolio NEW YORK, NY 17,06917.1k $46.1k $46.1k 0.00% Added +2.3k +2,300
6 UBS Group AG 0.00% of their portfolio ZURICH, V8 15,95316.0k $43.1k $43.1k 0.00% New
7 BANK OF AMERICA CORP /DE/ 0.00% of their portfolio CHARLOTTE, NC 150150 $405 $405 0.00% Unchanged
8 OSAIC HOLDINGS, INC. 0.00% of their portfolio SCOTTSDALE, AZ 100100 $270 $270 0.00% New
9 MORGAN STANLEY 0.00% of their portfolio NEW YORK, NY 66 $16 $16 0.00% Reduced -12 -12
10 Cornerstone Planning Group LLC 0.00% of their portfolio FAIRFIELD, NJ 55 $18 $18 0.00% Unchanged
11 CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0.00% of their portfolio BIRMINGHAM, AL 00 $0 $0 0.00% Unchanged